作者
Caitlin N Suire, Samer O Abdul-Hay, Tomoko Sahara, Dongcheul Kang, Monica K Brizuela, Paul Saftig, Dennis W Dickson, Terrone L Rosenberry, Malcolm A Leissring
发表日期
2020/12
期刊
Alzheimer's research & therapy
卷号
12
页码范围
1-13
出版商
BioMed Central
简介
Background
Cathepsin D (CatD) is a lysosomal protease that degrades both the amyloid β-protein (Aβ) and the microtubule-associated protein, tau, and has been genetically linked to late-onset Alzheimer disease (AD). Here, we sought to examine the consequences of genetic deletion of CatD on Aβ proteostasis in vivo and to more completely characterize the degradation of Aβ42 and Aβ40 by CatD.
Methods
We quantified Aβ degradation rates and levels of endogenous Aβ42 and Aβ40 in the brains of CatD-null (CatD-KO), heterozygous null (CatD-HET), and wild-type (WT) control mice. CatD-KO mice die by ~ 4 weeks of age, so tissues from younger mice, as well as embryonic neuronal cultures, were investigated. Enzymological assays and surface plasmon resonance were employed to quantify the kinetic parameters (KM, kcat) of CatD-mediated degradation of monomeric human Aβ42 vs. Aβ40, and the …
引用总数
202020212022202320241892110
学术搜索中的文章